Dr. Andrew Doan
M.D. | Pediatric Hematology-Oncology | Male
Dr. Andrew Doan, M.D. is a Los Angeles, California based Pediatric doctor with medical specialization in
Pediatric Hematology-Oncology.
Current practice location of Dr. Andrew Doan is
4650 W Sunset Blvd # 54, Los Angeles, California - 90027-6062. He can be contacted on phone at
323-361-2238.
Dr. Andrew Doan is a sole proprietor of his business.
NPI number (Unique professional ID) for Dr. Andrew Doan is
1588910558 which was assigned by NPPES on 27 Jul, 2012 and it was last updated on 21 Jul, 2022.
Dr. Andrew Doan license number is
A142694 for Pediatrics Pediatric Hematology-Oncology (2080P0207X) in California.
Dr. Andrew Doan is trained in the combination of pediatrics, hematology and oncology to recognize and manage pediatric blood disorders and cancerous diseases.
Complete Profile:
Dr. Andrew Doan basic information including his official name, gender, specialization, credentials etc. are as mentioned below.
| Specialization : | Pediatrics Pediatric Hematology-Oncology |
|---|
| Provider Name : | Dr. Andrew Doan |
|---|
| Credential : | M.D. |
|---|
| Gender : | Male |
|---|
Business Address:
Dr. Andrew Doan address, contact phone number and fax are as below. Patients can directly walkin to the clinic or can call on the below given phone number for appointment.
| Primary Address : | 4650 W Sunset Blvd # 54
Los Angeles, CA, 90027-6062
United States |
|---|
| Phone Number : | 323-361-2238 |
|---|
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
| NPI Number : | 1588910558 |
|---|
| NPI Entity Type : | Individual |
|---|
| First Enrolment Date : | 27 Jul, 2012 |
|---|
| Last Updated On : | 21 Jul, 2022 |
|---|
Medicare Participation:
Dr. Andrew Doan participates in medicare and accepts medicare insurance either directly or through association with group practice or medical facility.
| Medicare PECOS ID : | 8022380617 |
|---|
| Medicare Enrollment ID : | I20170816003248 |
|---|
| Primary Specialty : | Hematology/oncology |
|---|
| Medical School : | Other |
|---|
| Graduation Year : | 2009 |
|---|
| Accepts Medicare? | Yes. Dr. Andrew Doan accepts medicare insurance. |
|---|
Group Practice Association:
Dr. Andrew Doan is associated with following Group Practice Organizations. Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name with which Dr. Andrew Doan is associated with along with the number of members in that group. He may also accept medicare indirectly via these group practices.
| Organisation Name : | Group Practice ID | No. of Members | Practice Address | Group Accepts Medicare |
|---|
| Childrens Hospital Los Angeles Medical Group Inc | 0143126920 | 163 | 4650 W Sunset Blvd
Los Angeles, CA - 900276062
Ph: 3233618408 | Yes |
Licenses and Specialities:
Physicians/Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Andrew Doan are as mentioned. Primary taxonomy code for Dr. Andrew Doan, M.D. is
2080P0207X (Pediatrics Pediatric Hematology-Oncology).
| Taxonomy Code | Speciality | Primary | License No. | State |
|---|
| 2080P0207X | Pediatrics Pediatric Hematology-Oncology | Yes | A142694 | CA |
Mailing Address:
Mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned business address only.
| Mailing Address : | 4650 W Sunset Blvd # 54
Los Angeles, CA, 90027-6062
United States |
|---|
| Phone Number : | 323-361-8174 |
|---|
Business Location:
Patients can refer following map for directions to
Dr. Andrew Doan practice address. Don't forget to take prior appointment before visiting.
** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 January, 2024.